Cwm, LLC Immunic, Inc. Transaction History

Cwm, LLC

$24.1 Billion
Q4 2024

A detailed history of Cwm, LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Cwm, LLC holds 8,642 shares of IMUX stock, worth $8,469. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,642

Holding current value

$8,469

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 04, 2025	BUY	$1.0 - $1.61 $8,642 - $13,913	8,642 New	8,642 $9,000
Q2 2022 Jul 28, 2022	BUY	$3.13 - $12.25 $37 - $147	12 New	12 $0

Others Institutions Holding IMUX

# of Institutions

Shares Held

56.4M

Call Options Held

100

Put Options Held

350K

Bvf Inc San Francisco, CA

8.9M
Shares

$8.72 Million
0.47% of portfolio
Avidity Partners Management LP Dallas, TX

8.27M
Shares

$8.1 Million
0.84% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

7.29M
Shares

$7.15 Million
1.02% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

5.59M
Shares

$5.48 Million
0.02% of portfolio
Janus Henderson Group PLC London, X0

5.1M
Shares

$5 Million
0.0% of portfolio

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $30M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account